Raiffeisen Bank International (OTCPK:RAIFY) is currently undervalued compared to its closest peers, which doesn’t seem to be warranted given its improving fundamentals. The bank has high exposure to Central and Eastern Europe, of which Russia and Ukraine are two important markets.
This was quite bad during 2014-15, but since then, Raiffeisen has implemented a restructuring program,....More>>>
Credit Suisse analyst Gregory Lewis and team highlight seven factors that will help sway how investors react to earnings from offshore drillers like Transocean (RIG), Noble (NE),Diamond Offshore Drilling (DO), Seadrill (SDRL), and Ensco (ESV):
Matthew Lloyd/Bloomberg News
Earnings Season: Things To Watch
1) Extending Duration.Transocean remains focused on increasing financial....More>>>
Shares of Advanced Micro Devices Inc (NASDAQ:AMD) have had a few rough days, but should you buy into the stock today?
Shares of Sunnyvale, California-based Advanced Micro Devices Inc (NASDAQ:AMD)have had a rough couple of days. AMD stock closed the day 3.2% lower on the 4th of April, on the back of a bearish note by Pacific Crest’s MikeMcConnell primarily pertaining to....More>>>
Are Berkshire Hathaways best days behind it? Warren Buffett seems to think so. In an essay to mark the firms 50th anniversary, the Oracle of Omaha wrote in 2015 that Berkshire Hathaways future long-term gains will not come close to those achieved in the past 50 years. (The words in italics are reproduced exactly as they appeared.) The numbers have become too big, Buffett goes on to say about....More>>>
I don't know about you, but I'm fascinated by "world champions" – folks who have literally reached the top of their game. I've been fortunate to meet a lot folks like this (in a variety of fields… namely sports, business, and music). A lot of my own success comes from learning directly from them, and mimicking things they do. I'm SO curious....More>>>
Making his first extended comments since Fox News dropped his top-rated show last week, Bill O’Reilly said he was taken aback by how his 21-year run at the network came to an end.
“I am sad that I’m not on television anymore,” O’Reilly said in a podcast posted Monday on his official website. “I was very surprised how it all turned out. I can’t....More>>>
During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.
After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 82 big blue chips.
Chances are that you have at least one of these....More>>>
"I personally sold all my gold and gold stocks yesterday," I told a crowd of 500 gold bugs at the Sprott Natural Resource Symposium in Vancouver at the end of July. The crowd was shocked… But my timing was nearly perfect. Gold is down 12% since the beginning of August. And gold stocks – as measured by the VanEck Vectors Junior Gold Miners Fund (GDXJ) –....More>>>
Portola Pharmaceuticals (NASDAQ:PTLA) was one of the year’s most hotly anticipated biotech IPOs when it was brought public by Morgan Stanley and Credit Suisse in May 2013 at $14.50/share. Shares quickly rose to the mid-$20s, but then did little afterwards for the next 18 months.
Since that time though, Portola has taken shareholders on a ludicrous ride and now the story has....More>>>